Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C-Reference-Cited by-同舟云学术

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C

Published:2023-02-22 Issue:6 Volume:68 Page:2738-2746
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Bonkovsky Herbert L.^ORCID,Rudnick Sean P.,Ma Christopher D.,Overbey Jessica R.,Wang Kelly,Faust Denise,Hallberg Csilla,Hedstrom Karli,Naik Hetanshi,Moghe Akshata,Anderson Karl E.

Funder

Gilead Sciences

NIDDK

NCATS

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-023-07859-8.pdf

Reference24 articles.

1. Bonkovsky HL, Guo J-T, Hou W, Li T, Narang T, Thapar M. Porphyrin and heme metabolism and the porphyrias. Compr Physiol. 2013;3:365–401.

2. Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med 2017;377:862–872.

3. Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: Review and recent progress. Hepatol Commun 2019;3:193–206.

4. Sixel-Dietrich F, Doss M. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res 1985;278:13–16.

5. Weiss Y, Chen B, Yasuda M, Nazarenko I, Anderson KE, Desnick RJ. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations. Mol Genet Metab 2019;128:363–366.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring current and emerging therapies for porphyrias;Liver International;2024-05-30

2. Update on the Porphyrias;Annual Review of Medicine;2024-01-29